PNC Financial Services Group
TRIB

PNC Financial Services Group’s Trinity Biotech TRIB Stock Holding History

PNC Financial Services Group’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1
Closed -$1K – 4211
2016
Q4 		$1K Hold
1
– – ﹤0.01% 3937
2016
Q3 		$2K Sell
1
-133
-99% -$248K ﹤0.01% 3833
2016
Q2 		$227K Hold
134
– – ﹤0.01% 2000
2016
Q1 		$235K Hold
134
– – ﹤0.01% 2005
2015
Q4 		$237K Sell
134
-14
-9% -$24.8K ﹤0.01% 1974
2015
Q3 		$252K Buy
148
+14
+10% +$33.8K ﹤0.01% 1983
2015
Q2 		$364K Hold
134
– – ﹤0.01% 1836
2015
Q1 		$388K Buy
134
+1
+0.8% +$2.77K ﹤0.01% 1798
2014
Q4 		$350K Hold
133
– – ﹤0.01% 1743
2014
Q3 		$366K Sell
133
-112
-46% -$364K ﹤0.01% 1651
2014
Q2 		$844K Buy
245
+1
+0.4% +$3.56K ﹤0.01% 1155
2014
Q1 		$887K Buy
244
+111
+83% +$437K ﹤0.01% 1119
2013
Q4 		$502K Hold
133
– – ﹤0.01% 1378
2013
Q3 		$436K Buy
+133
New +$389K ﹤0.01% 1430

Other funds holding TRIB

PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $486M AUM 50.29% 1-Year Est. Return
2L
22NW LP Seattle, Washington $105M AUM 38.33% 1-Year Est. Return
SCM
Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return

PNC Financial Services Group's TRIB Position: Q1 2017 in Review

PNC Financial Services Group sold out of Trinity Biotech (TRIB) in Q1 2017, closing a stake of 1 share — an estimated $1K sold.

PNC Financial Services Group first reported a position in TRIB in Q3 2013 and held it in 14 quarters. The position peaked at $887K in Q1 2014. 67 funds tracked by Wall St. Rank hold TRIB as of Q1 2017.

  • PNC Financial Services Group reported no remaining Trinity Biotech position as of Q1 2017 after selling out during the quarter.
  • PNC Financial Services Group sold 1 Trinity Biotech share in Q1 2017, an estimated $1K.
  • PNC Financial Services Group first reported a position in Trinity Biotech in Q3 2013 and held it in 14 quarters.
  • PNC Financial Services Group's Trinity Biotech position peaked at $887K in Q1 2014.
  • 67 funds tracked by Wall St. Rank held Trinity Biotech as of Q1 2017.

Based on PNC Financial Services Group's 13F filing for Q1 2017, filed 12 May 2017.